A high affinity ligand for GABAA-receptor containing α5 subunit antagonizes ethanol's neurobehavioral effects in Long-Evans rats

被引:37
作者
McKay, PF
Foster, KL
Mason, D
Cummings, R
Garcia, M
Williams, LS
Grey, C
McCane, S
He, XH
Cook, JM
June, HL
机构
[1] Indiana Univ Purdue Univ, Dept Psychol, Psychobiol Program, LD 124, Indianapolis, IN 46202 USA
[2] Univ Wisconsin, Dept Chem, Milwaukee, WI 53201 USA
关键词
gamma-aminobutyric acid type A (GABA center dot) receptor; alpha; subunit; alcohol sedation; alcohol reinforcement; locomotor activity; motor impairing effects;
D O I
10.1007/s00213-003-1671-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale. Previously, we reported that the GABA(A) receptor containing alpha(5) subunit played a significant role in the reinforcing actions of EtOH in rats selectively bred to consume alcohol. However, the role of the alpha(5) receptor in regulating the neurobehavioral effects of EtOH in outbred rats is not known. Objective. In the present study, RY024, a novel benzodiazepine (BDZ) inverse agonist with high affinity (K(d)similar to 0.40 nM) and selectivity (similar to67.3-fold) for the alpha(5) receptor, was investigated for its capacity to antagonize EtOH's reinforcing, motor impairing, and sedative effects in Long-Evans rats. Methods. Rats were trained to lever press for EtOH under a fixed-ratio 1 schedule of reinforcement. Subsequent studies evaluated EtOH's motor-impairing effects in an oscillating bar task, while EtOH's sedative effects were measured in the open field. Results. RY024 (0.125-3.5 mg/kg; IP) markedly reduced EtOH-maintained responding with no effects on water responding, except for the highest dose. RY024 (3.0-15 mg/kg; IP) also reversed the motor impairing effects of a moderate (0.75 g/kg), and intoxicating EtOH dose (1.25 g/kg) in the absence of intrinsic effects. Finally, RY024 (7.5 mg/kg) attenuated the sedation produced by the 1.25 g/kg EtOH dose; however, it failed to attenuate the sedation induced by the 0.75 g/kg EtOH dose. Given alone, RY024 exhibited intrinsic effects in the open field. Conclusion. The results suggest the GABA(A) receptor containing alpha(5) subtype plays an important role in regulating the reinforcing, motor-impairing, and sedative effects of alcohol in outbred rats.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 32 条
[1]  
Barnard EA, 1998, PHARMACOL REV, V50, P291
[2]   Responsivity and development of tolerance to the motor impairing effects of moderate doses of ethanol in alcohol-preferring (P) and -nonpreferring (NP) rat lines [J].
Bell, RL ;
Stewart, RB ;
Woods, JE ;
Lumeng, L ;
Li, TK ;
Murphy, JM ;
McBride, WJ .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 25 (05) :644-650
[3]   SELECTIVE ANTAGONISM OF ACUTE ETHANOL-INDUCED MOTOR DISTURBANCES BY CENTRALLY ADMINISTERED RO 15-4513 IN MICE [J].
DAR, MS .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 42 (03) :473-479
[4]  
DRASKI LJ, 1996, PHARM EFFECTS ETHANO, P244
[5]  
JACKSON HC, 1995, BENZODIAZEPINE RECEP, P113
[6]  
June HL, 1995, EXP CLIN PSYCHOPHARM, V3, P252
[7]   Benzodiazepine receptor antagonists modulate the actions of ethanol in alcohol-preferring and -nonpreferring rats [J].
June, HL ;
Devaraju, SL ;
Eggers, MW ;
Williams, JA ;
Cason, CR ;
Greene, TL ;
Leveige, T ;
Braun, MR ;
Torres, L ;
Murphy, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (2-3) :139-151
[8]   The effects of the novel benzodiazepine receptor inverse agonist Ru 34000 on ethanol-maintained behaviors [J].
June, HL ;
Eggers, MW ;
Warren-Reese, C ;
DeLong, J ;
Ricks-Cord, A ;
Durr, LF ;
Cason, CR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 350 (2-3) :151-158
[9]   GABAA receptors containing α5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors:: An extended ethanol reward circuitry [J].
June, HL ;
Harvey, SC ;
Foster, KL ;
McKay, PF ;
Cummings, R ;
Garcia, M ;
Mason, D ;
Grey, C ;
McCane, S ;
Williams, LS ;
Johnson, TB ;
He, XH ;
Rock, S ;
Cook, JM .
JOURNAL OF NEUROSCIENCE, 2001, 21 (06) :2166-2177
[10]   The novel benzodiazepine inverse agonist RO19-4603 antagonizes ethanol motivated behaviors: neuropharmacological studies [J].
June, HL ;
Torres, L ;
Cason, CR ;
Hwang, BH ;
Braun, MR ;
Murphy, JM .
BRAIN RESEARCH, 1998, 784 (1-2) :256-275